在状细胞病的基因治疗后,血造干细胞的克隆选择
Michael Spencer Chapman1,2,3, Alyssa H Cull4, Marioara F Ciuculescu5
1Wellcome Sanger Institute, Hinxton, UK.
Nature medicine
|November 17, 2023
概括
状细胞疾病 (SCD) 的基因疗法显示出潜力,但骨髓性恶性瘤是令人担忧的. 全基因组测序揭示了治疗后造血干细胞 (HSC) 中驱动突变的增加,这表明对先前存在的突变进行了积极选择.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 基因疗法 (GT) 提供了状细胞疾病 (SCD) 的治愈方法.
- 人们对GT后的骨髓质恶性瘤存在担忧,潜在的机制正在调查中.
- 在GT之后,了解造血干细胞 (HSC) 的克隆动力学至关重要.
研究的目的:
- 在GT之前和之后的SCD患者中绘制HSC的体质突变和克隆格局.
- 调查GT对基因修饰和未修饰HSCs的克隆进化的影响.
- 为了确定与骨髓瘤或GT后的克隆性血液形成相关的潜在驱动突变.
主要方法:
- 从六名SCD患者的HSC全基因组测序在GT前后的时间点.
- 遗传学分析来追踪克隆结构和体质突变.
- 在基因修改和未修改的HSC中评估突变负担和克隆扩张.
主要成果:
- 在GT前,HSC种群是多克隆的,具有可变的突变负担.
- 在GT后,在基因修饰或未修饰的HSC中没有检测到任何克隆扩张.
- 在两种细胞类型中都观察到潜在驱动突变 (例如,DNMT3A,EZH2) 的频率增加,这表明积极选择.
结论:
- 在SCD患者中的GT可能导致具有先前存在的驱动突变的HSC的积极选择.
- 这种选择可能会导致克隆性血液形成或骨髓性瘤.
- 需要进一步的研究来确定这些选择的突变克隆的长期命运.
相关概念视频
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:22Bone Marrow Sampling and Transplants
334
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
334
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K